Literature DB >> 27208973

Chromothripsis and epigenomics complete causality criteria for cannabis- and addiction-connected carcinogenicity, congenital toxicity and heritable genotoxicity.

Albert Stuart Reece1, Gary Kenneth Hulse2.   

Abstract

The recent demonstration that massive scale chromosomal shattering or pulverization can occur abruptly due to errors induced by interference with the microtubule machinery of the mitotic spindle followed by haphazard chromosomal annealing, together with sophisticated insights from epigenetics, provide profound mechanistic insights into some of the most perplexing classical observations of addiction medicine, including cancerogenesis, the younger and aggressive onset of addiction-related carcinogenesis, the heritability of addictive neurocircuitry and cancers, and foetal malformations. Tetrahydrocannabinol (THC) and other addictive agents have been shown to inhibit tubulin polymerization which perturbs the formation and function of the microtubules of the mitotic spindle. This disruption of the mitotic machinery perturbs proper chromosomal segregation during anaphase and causes micronucleus formation which is the primary locus and cause of the chromosomal pulverization of chromothripsis and downstream genotoxic events including oncogene induction and tumour suppressor silencing. Moreover the complementation of multiple positive cannabis-cancer epidemiological studies, and replicated dose-response relationships with established mechanisms fulfils causal criteria. This information is also consistent with data showing acceleration of the aging process by drugs of addiction including alcohol, tobacco, cannabis, stimulants and opioids. THC shows a non-linear sigmoidal dose-response relationship in multiple pertinent in vitro and preclinical genotoxicity assays, and in this respect is similar to the serious major human mutagen thalidomide. Rising community exposure, tissue storage of cannabinoids, and increasingly potent phytocannabinoid sources, suggests that the threshold mutagenic dose for cancerogenesis will increasingly be crossed beyond the developing world, and raise transgenerational transmission of teratogenicity as an increasing concern.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cannabis; Chromothripsis; Dose-response relationship; Epigenetics; Foetal malformations; Heritable; Interdisciplinary; Microtubules; Oncogenesis; Population effects; Threshold dose; Transgenerational; Tubulin

Mesh:

Substances:

Year:  2016        PMID: 27208973     DOI: 10.1016/j.mrfmmm.2016.05.002

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  25 in total

1.  Geospatiotemporal and causal inference study of cannabis and other drugs as risk factors for female breast cancer USA 2003-2017.

Authors:  Albert Stuart Reece; Gary Kenneth Hulse
Journal:  Environ Epigenet       Date:  2022-03-01

2.  Higher Marijuana use among Young Adults Persists Even during Pregnancy.

Authors:  Priya S Gupta; Krishna Upadhya; Pamela Matson; Susanna Magee; Hoover Adger; Maria Trent
Journal:  J Gynaecol Obstet Adv       Date:  2021-04-29

3.  Geotemporospatial and causal inference epidemiological analysis of US survey and overview of cannabis, cannabidiol and cannabinoid genotoxicity in relation to congenital anomalies 2001-2015.

Authors:  Albert Stuart Reece; Gary Kenneth Hulse
Journal:  BMC Pediatr       Date:  2022-01-19       Impact factor: 2.125

4.  A geospatiotemporal and causal inference epidemiological exploration of substance and cannabinoid exposure as drivers of rising US pediatric cancer rates.

Authors:  Albert Stuart Reece; Gary Kenneth Hulse
Journal:  BMC Cancer       Date:  2021-02-25       Impact factor: 4.430

Review 5.  Impacts of cannabinoid epigenetics on human development: reflections on Murphy et. al. 'cannabinoid exposure and altered DNA methylation in rat and human sperm' epigenetics 2018; 13: 1208-1221.

Authors:  Albert Stuart Reece; Gary Kenneth Hulse
Journal:  Epigenetics       Date:  2019-07-11       Impact factor: 4.528

Review 6.  Can Cannabidiol Affect the Efficacy of Chemotherapy and Epigenetic Treatments in Cancer?

Authors:  Courtney Griffiths; James Aikins; David Warshal; Olga Ostrovsky
Journal:  Biomolecules       Date:  2021-05-20

7.  Epidemiological overview of multidimensional chromosomal and genome toxicity of cannabis exposure in congenital anomalies and cancer development.

Authors:  Albert Stuart Reece; Gary Kenneth Hulse
Journal:  Sci Rep       Date:  2021-07-06       Impact factor: 4.379

8.  Cannabis exposure as an interactive cardiovascular risk factor and accelerant of organismal ageing: a longitudinal study.

Authors:  Albert Stuart Reece; Amanda Norman; Gary Kenneth Hulse
Journal:  BMJ Open       Date:  2016-11-07       Impact factor: 2.692

9.  Irinotecan and Δ⁸-Tetrahydrocannabinol Interactions in Rat Liver: A Preliminary Evaluation Using Biochemical and Genotoxicity Markers.

Authors:  Ana Lucić Vrdoljak; Nino Fuchs; Anja Mikolić; Suzana Žunec; Irena Brčić Karačonji; Andreja Jurič; Ljerka Prester; Vedran Micek; Marijana Neuberg; Samir Čanović; Gordan Mršić; Nevenka Kopjar
Journal:  Molecules       Date:  2018-06-01       Impact factor: 4.411

Review 10.  Chromoanagenesis: cataclysms behind complex chromosomal rearrangements.

Authors:  Franck Pellestor
Journal:  Mol Cytogenet       Date:  2019-02-11       Impact factor: 2.009

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.